Direct delivery to tumors remains a problem in most nanoparticle applications because the immune system rapidly removes circulating nanoparticles by ultimately accumulating them in the liver and kidneys. Can nano graphene oxide with enhanced tunable fluorescence be used as bioimaging probes without attaching antibodies?